探讨达芬奇单通道SP机器人在肝胰手术中的应用。

使用达芬奇SP机器人平台，分别对1例胰尾囊腺瘤、1例肝左外叶肝癌、1例肝左叶混合型肝癌的患者实施了胰腺肿瘤剜除术、肝左外叶切除术、扩大肝左外叶切除+区域淋巴结清扫术。

3例患者均成功的接受了单通道机器人手术。装机时间分别为20、14、9 min，镜下手术时间分别为55、49、76 min，总手术时间分别为100、83、105 min，术中出血量分别为5、10、20 ml，术后视觉疼痛模拟评分分别为3/10、3/10、3/10分，术后1 d视觉疼痛模拟评分分别为1/10、1/10、1/10分，3例患者均无并发症的发生。

初步手术经验提示单通道机器人手术在欠复杂肝胆胰手术中是安全、可行的，较传统单孔手术优势显著，但仍待进一步经验积累和对比研究论证其临床价值，明确手术适应证。

Exploring the application of da Vinci single-channel SP robot in hepatopancreas surgery.

Using the da Vinci SP robotic platform, enucleation of pancreatic tumor, left lateral lobe resection, and enlarged left lateral lobectomy + regional lymph node dissection were performed on one patient with pancreatic tail cystadenoma, one patient with left lateral hepatic hepatic carcinoma, and one patient with mixed liver cancer in left hepatic lobe.

All 3 patients successfully underwent single-channel robotic surgery. The installation time were 20, 14 and 9 minutes, the operation time were 55, 49 and 76 minutes, the total operation time were 100, 83 and 105 minutes, the blood loss were 5, 10 and 20 ml, and the postoperative visual analogue pain scale were 3/10, 3/10 and 3/10, the visual analogue pain scale on the first day after surgery were 1/10, 1/10 and 1/10, all 3 patients had no complications.

Preliminary surgical experience suggests that single-channel robotic surgery is safe and feasible in simple hepatobiliary and pancreatic surgery, and has significant advantages over traditional single-port surgery. However, further experience accumulation and comparative studies are needed to demonstrate its clinical value and clarify surgical indications.